The potential importance of the built-environment microbiome and its impact on human health.

Anthropocene architectural design evolution metaorganism microbiome

Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
14 May 2024
Historique:
medline: 25 4 2024
pubmed: 25 4 2024
entrez: 25 4 2024
Statut: ppublish

Résumé

There is increasing evidence that interactions between microbes and their hosts not only play a role in determining health and disease but also in emotions, thought, and behavior. Built environments greatly influence microbiome exposures because of their built-in highly specific microbiomes coproduced with myriad metaorganisms including humans, pets, plants, rodents, and insects. Seemingly static built structures host complex ecologies of microorganisms that are only starting to be mapped. These microbial ecologies of built environments are directly and interdependently affected by social, spatial, and technological norms. Advances in technology have made these organisms visible and forced the scientific community and architects to rethink gene-environment and microbe interactions respectively. Thus, built environment design must consider the microbiome, and research involving host-microbiome interaction must consider the built-environment. This paradigm shift becomes increasingly important as evidence grows that contemporary built environments are steadily reducing the microbial diversity essential for human health, well-being, and resilience while accelerating the symptoms of human chronic diseases including environmental allergies, and other more life-altering diseases. New models of design are required to balance maximizing exposure to microbial diversity while minimizing exposure to human-associated diseases. Sustained trans-disciplinary research across time (evolutionary, historical, and generational) and space (cultural and geographical) is needed to develop experimental design protocols that address multigenerational multispecies health and health equity in built environments.

Identifiants

pubmed: 38662573
doi: 10.1073/pnas.2313971121
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2313971121

Subventions

Organisme : Canadian Institute for Advanced Research (ICRA)
ID : HMB program

Déclaration de conflit d'intérêts

Competing interests statement:The authors declare no competing interest.

Auteurs

Thomas C G Bosch (TCG)

Zoological Institute, University of Kiel, Kiel 24118, Germany.
Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.

Mark Wigley (M)

Graduate School of Architecture, Planning and Preservation, Columbia University, New York, NY 10027.

Beatriz Colomina (B)

School of Architecture, Princeton University, Princeton, NJ 08544.

Brendan Bohannan (B)

The Institute of Ecology and Evolution, University of Oregon, Eugene, OR 97403-5289.

Forrest Meggers (F)

Princeton University School of Architecture & Andlinger Center for Energy and the Environment, Princeton, NJ 08540.

Katherine R Amato (KR)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Anthropology, Northwestern University, Evanston, IL 60208.

Meghan B Azad (MB)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Pediatrics and Child Health, University of Manitoba, Winnipeg, MB R3E 0Z3, Canada.
Department of Community Health Sciences, University of Manitoba, Winnipeg, MB R3E 3P5, Canada.

Martin J Blaser (MJ)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Children's Hospital Research Institute of Manitoba, Winnipeg, MB R3E 3P4, Canada.
Center for Advanced Biotechnology and Medicine at Rutgers Biomedical and Health Sciences, Rutgers University, Piscataway, NJ 08854-8021.

Kate Brown (K)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Program in Science, Technology and Society, Massachusetts Institute of Technology, Cambridge, MA 02139.

Maria Gloria Dominguez-Bello (MG)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Biochemistry and Microbiology, Rutgers University, New Brunswick, NJ 08901.
Department of Anthropology, Rutgers University, New Brunswick, NJ 08901.

Stanislav Dusko Ehrlich (SD)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Institute of Neurology, University College London, London WC1N 3RX, United Kingdom.

Eran Elinav (E)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Systems Immunology Department, Weizmann Institute of Science, Rehovot 761000, Israel.
Division of Microbiome & Cancer, Deutsches Krebsforschungszentrum, 69120 Heidelberg, Germany.

B Brett Finlay (BB)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Michael Smith Laboratories, University of British Columbia, Vancouver, BC V6T 1Z4, Canada.

Kate Geddie (K)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Medical and Related Sciences Centre, The Canadian Institute for Advanced Research, Toronto, ON M5G 1L7, Canada.

Naama Geva-Zatorsky (N)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Technion Integrated Cancer Center, Technion-Israel Institute of Technology, Haifa 3525433, Israel.
Department of Cell Biology and Cancer Science, Technion-Israel Institute of Technology, Haifa 3525433, Israel.

Tamara Giles-Vernick (T)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Anthropology & Ecology of Disease Emergence, Institut Pasteur, Université Paris Cité, Paris 75015, France.

Philippe Gros (P)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Biochemistry, McGill University, Montreal, QC H3G 1Y6, Canada.

Karen Guillemin (K)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Institute of Molecular Biology, University of Oregon, Eugene, OR 97403.

Louis-Patrick Haraoui (LP)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Microbiology and Infectious Diseases, Université de Sherbrooke, Canada J1E 4K8.

Elizabeth Johnson (E)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
College of Human Ecology, Cornell University, Ithaka NY 14853.

Frédéric Keck (F)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Laboratoire d'Anthropologie Sociale, Collège de France, Paris 75005, France.

Jamie Lorimer (J)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
School of Geography and the Environment, University of Oxford, OX1 3QY, United Kingdom.

Margaret J McFall-Ngai (MJ)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Division of Biology and Biological Engineering, Caltech, Pasadena, CA 91125.

Mark Nichter (M)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
School of Anthropology, University of Arizona, Tucson, AZ 85721.

Sven Pettersson (S)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Nanyang Technological University, Singapore 637715, Singapore.

Hendrik Poinar (H)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Anthropology, McMaster University, Hamilton, ON L8S 4M4, Canada.

Tobias Rees (T)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
LIMN, Berkeley, CA 94708.

Carolina Tropini (C)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Microbiology and Immunology and School of Biomedical Engineering, University of British Columbia, Vancouver, BC V6T 1Z3, Canada.

Eduardo A Undurraga (EA)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Escuela de Gobierno, Pontificia Universidad Católica de Chile, Santiago 7820436, Chile.

Liping Zhao (L)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Biochemistry and Microbiology, Rutgers University, New Brunswick, NJ 08901.

Melissa K Melby (MK)

Humans and the Microbiome Program, Canadian Institute for Advanced Research, Toronto, ON M5G 1M1, Canada.
Department of Anthropology, University of Delaware, Newark, DE 19716.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH